Scindy Pharmaceutical’s next-generation in vivo lipid nanoparticle technology integrates cutting-edge targeted delivery strategies while building on traditional methods. Our In vivo NeoLNP™ Kit enhances the accuracy and efficiency of RNA delivery through innovative lipid formulations and personalized targeting ligands, overcoming the limitations of traditional LNP technology in non-liver organ RNA delivery and achieving effective targeted delivery to extrahepatic organs.

The NeoLNP™ Lung-Targeted RNA Transfection Kit (SDR6005) brings revolutionary breakthroughs to lung disease research and treatment with its exceptional performance.

Compatible with Multiple RNA Types:

Suitable for delivering siRNA, gRNA, mRNA, circRNA, and more, offering broad application potential in gene therapy and research.

High Lung Targeting:

Achieves up to 94% lung targeting, significantly reducing non-specific transfection in other organs, improving treatment safety and efficacy.

High Safety:

● Uses biodegradable lipid materials with excellent biocompatibility.

● Free of ethanol and other organic solvents.

● Up to 94% organ-targeted distribution, with minimal impact on other tissues or organs, ensuring reliable and effective treatment.

Why Choose in vivo NeoLNP™ Transfection Kit?

● Efficient: Maintains stable high transfection levels regardless of injection method.

● Flexible: Customizable for systemic or localized RNA delivery based on research goals.

● User-Friendly: Optimized delivery solutions enable rapid, efficient RNA encapsulation, simplifying experiments.

With the in vivo NeoLNP™ Transfection Kit, researchers can flexibly utilize multiple delivery routes to achieve precise RNA delivery, meeting unique research needs. From broad systemic applications to highly specific organ-targeted delivery, this kit is a powerful tool for cutting-edge RNA research.

Ready-to-Use LNP In Vivo Delivery Technology

The in vivo NeoLNP™ Kit stands out for its rapid and efficient RNA encapsulation capabilities. Compared to traditional methods, it requires no complex equipment, achieving efficient encapsulation through simple mixing with RNA solutions, significantly reducing preparation time. This innovation enhances RNA stability and ensures efficient transfection, offering a new transfection experience compared to traditional liposome-based nucleic acid adsorption methods.